Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Xi Chen
Affiliation
ORCID
Career Start Year
2008
Papers
87
H Index
37
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37487814
Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic.
Eur Urol Oncol
2024
36600118
Long-Term Impact of Medicaid Expansion on Colorectal Cancer Screening in Its Targeted Population.
Dig Dis Sci
2023
36065039
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
International Ophthalmology
2023
37594617
A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer.
2023
36708009
Investigating the racial gap in prostate cancer screening with prostate-specific antigen among younger men from 2012 to 2020.
JNCI Cancer Spectr
2023
32398486
Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
Annals of Surgery
2022
35536695
Geographic Variability, Time Trends and Association of Preoperative Magnetic Resonance Imaging with Surgical Outcomes for Elderly United States Men with Prostate Cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
J Urol
2022
36583645
MiR-125b-5p is targeted by curcumin to regulate the cellular antioxidant capacity.
2022
36685912
Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma.
2022
34571860
A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients.
Cells
2021
33577785
Proteogenomic and metabolomic characterization of human glioblastoma.
Cancer Cell
2021
33934205
A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy.
Cancer Immunology, Immunotherapy
2021
34322745
Prognostic nomogram to predict the overall survival of patients with early-onset colorectal cancer: a population-based analysis.
International Journal of Colorectal Disease
2021
33417831
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer Cell
2021
33388316
Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
Gastroenterology
2021
32843316
Does Intentional Support of Degree Programs in General Surgery Residency Affect Research Productivity or Pursuit of Academic Surgery? A Multi-Institutional Study.
2020
32409730
Prostate cancer management costs vary by disease stage at presentation.
Prostate Cancer Prostatic Dis
2020
32054505
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
J Transl Med
2020
32335060
Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.
2020
31923397
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2020
31916588
Minimally invasive cancer surgery is associated with a lower risk of venous thromboembolic events.
Journal of Surgical Oncology
2020
33285687
Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis.
Medicine (United States)
2020
31373854
A Hallmark-Based Six-Gene Expression Signature to Assess Colorectal Cancer and Its Recurrence Risk.
Genetic Testing and Molecular Biomarkers
2019
31752878
Transcriptome-wide analysis of changes in the fetal placenta associated with prenatal arsenic exposure in the New Hampshire Birth Cohort Study.
Environ Health
2019
30606770
Is a Tumor Suppressor Gene in Colorectal Cancer.
Molecular Cancer Research
2019
30587545
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance.
Clin Cancer Res
2019
30655319
Serine Threonine Kinase 17A Maintains the Epithelial State in Colorectal Cancer Cells.
Molecular Cancer Research
2019
30079384
Genomic Profiling of T-Cell Neoplasms Reveals Frequent <i>JAK1</i> and <i>JAK3</i> Mutations With Clonal Evasion From Targeted Therapies.
JCO Precis Oncol
2018
28716817
PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.
Mol Cancer Ther
2017
28389570
BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.
Gut
2017
28814670
MTG16 is a tumor suppressor in colitis-associated carcinoma.
JCI Insight
2017
27623752
Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples.
Scientific Reports
2016
27063517
Outcomes of cataract surgery with residents as primary surgeons in the Veterans Affairs Healthcare System.
Journal of Cataract and Refractive Surgery
2016
27176004
Comparison of Nanostring nCounter® Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.
PLoS ONE
2016
27270437
Myeloid translocation genes differentially regulate colorectal cancer programs.
Oncogene
2016
27310713
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
PLoS ONE
2016
26657862
MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.
J Clin Invest
2016
26084293
ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma.
Oncotarget
2015
25886164
Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
BMC Cancer
2015
25500541
Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis.
Oncogene
2015
25477325
Optimizing the sequence of anti-EGFR-targeted therapy in EGFR-mutant lung cancer.
Mol Cancer Ther
2015
25968920
Hhex is Required at Multiple Stages of Adult Hematopoietic Stem and Progenitor Cell Differentiation.
Stem Cells
2015
26053663
Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage.
Journal of Clinical Investigation
2015
24786788
Oncogenic protein MTBP interacts with MYC to promote tumorigenesis.
Cancer Research
2014
25320007
Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.
Cancer Res
2014
25267467
DupChecker: a bioconductor package for checking high-throughput genomic data redundancy in meta-analysis.
BMC Bioinformatics
2014
24465765
LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
PLoS One
2014
24866769
MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival.
Molecular Cancer Research
2014
25173427
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.
Nat Med
2014
24939623
Predictors of hemodynamic instability during surgery for pheochromocytoma.
Annals of Surgical Oncology
2014
1 - 50 of 87
Column Actions
Search
Recommended Authors
Collaborators
Mary Kay Washington
Co-authored papers
17
Bing Zhang
Baylor College of Medicine
Co-authored papers
8
Zhongming Zhao
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers
6
Stuart R Lipsitz
Harvard Medical School
Co-authored papers
4
Russell D Wolfinger
SAS Institute
Co-authored papers
4
Jing Zhu
Co-authored papers
3
Pei Wang
Co-authored papers
3
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Qing Kay Li
Co-authored papers
3
Matthew A Wyczalkowski
Washington University in St Louis
Co-authored papers
3
Antonio Colaprico
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers
3
Seungyeul Yoo
Co-authored papers
3
Henry Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers
3
Alexey I Nesvizhskii
University of Michigan ann arbor
Co-authored papers
3
Emily S Boja
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers
3
Melinda E Sanders
Co-authored papers
3
Ana I Robles
Co-authored papers
3
Christopher R Kinsinger
Co-authored papers
3
Mehdi Mesri
Co-authored papers
3
Peilin Jia
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers
3
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
3
Maciej Wiznerowicz
Co-authored papers
3
Tara Hiltke
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers
3
Mathangi Thiagarajan
Co-authored papers
3
Robert J Coffey
Co-authored papers
3
Yize Li
Co-authored papers
3
Azra Krek
Co-authored papers
2
Saravana M Dhanasekaran
Co-authored papers
2
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers
2
Deepak Mani
Co-authored papers
2
1 - 30